Evaluation of comparative efficacy of Nimba-Amalakyadi Choorna with that of Metformin in the management of Diabetes Mellitus Type II (Prameha)

Datta Meghe Institute of health sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients with either sex having age between 20 -60 years
•Patients recently diagnosed for uncomplicated NIDDM (type 2 diabetes) ( <6 months) and having
•ï?¶Fasting blood sugar level >100-125 mg/dl
•ï?¶Post meal blood sugar level > 140- 300 mg/dl
•ï?¶HbA1c level 5.7% - 8 %
•Patients with and old cases of type-2 DM not taking any other anti-hypoglycaemic drugs.
•Diabetic Patients suffering from Controlled Hypertension (Blood Pressure not more than >=140 mmHg or an average Diastolic Blood Pressure not more than >=90 mmHg)
•Patients willing to give informed consent

•Patients suffering from IDDM (Insulin dependent diabetes mellitus) & patient with Type -2 Diabetes patients on insulin therapy
•Patients suffering from Juvenile Diabetes or Gestational diabetes (ICD â?? 10 criteria 024)
•Impaired glucose tolerance (ICD- 10 criteria R73.0)
•DM with complications e.g. Retinopathy, Nephropathy, neuropathy ,previous history of coma
•Patients suffering from any current acute illness, uncontrolled hypertension

发起方

Datta Meghe Institute of health sciences